skip to main content

Diabetic kidney disease with albuminuria — ABIM Board MCQ

Instant feedback + full explanation. One question, done properly.

HardNephrologyDiabetic kidney disease with albuminuriaABIM Board

A 64-year-old with type 2 diabetes has eGFR 44 mL/min/1.73 m2 and UACR 780 mg/g despite maximized lisinopril. Potassium is 4.7 mEq/L and A1C is 7.3%. Which intervention most directly slows CKD progression?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: AAdd an SGLT2 inhibitor while continuing ACE inhibition

SGLT2 inhibition reduces kidney and cardiovascular events in albuminuric diabetic CKD at this eGFR and is layered on ACE inhibition. A modest initial eGFR dip is expected, while dual RAS blockade is harmful; protein loading and thiazide monotherapy do not provide the same disease-modifying benefit.

Reference: KDIGO 2024 Clinical Practice Guideline for Chronic Kidney Disease: https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf